An artificial alternative to antibiotics has been developed to fight hospital superbugs such as MRSA, according to an article on Forbes.com. The drug, Staphefekt, is reported to be the first new type of weapon to be added to the medical arsenal against infection in a quarter of a century.
Five out of six patients with MRSA (methicillin-resistant Staphylococcus aureus) skin infections were cured in a small-scale trial at the Public Health Laboratory in Kennemerland, the Netherlands, scientists reported at the Antibiotic Alternatives for the New Millennium conference in London yesterday, on Nov. 5.
Click here to read the entire article.
Source: Forbes.com
Latest from Quality Assurance & Food Safety
- Director General of IICA and Senior USDA Officials Meet to Advance Shared Agenda
- EFSA and FAO Sign Memorandum of Understanding
- Ben Miller Breaks Down Federal Cuts, State Bans and Traceability Delays
- Michigan Officials Warn Recalled ByHeart Infant Formula Remains on Store Shelves
- Puratos USA to Launch First Professional Chocolate Product with Cultured Cocoa
- National Restaurant Association Announces Federal Policy Priorities
- USDA Offloads Washington Buildings in Reorganization Effort
- IDFA Promotes Andrew Jerome to VP of Strategic Communications and Executive Director of Foundation
